|
T.EDT
|
If untreated patients with EAA>0.60 and MODS >9, not randomized (for...
|
|
T.EDT
|
Next monday, at Rodman & Renshaw conference in New York, when investors...
|
|
T.EDT
|
I would like to know, please, where do you take these bids and asks for a...
|
|
T.EDT
|
Few years ago, Xigris, drug for sepsis, was approved by FDA with a 6...
|
|
T.EDT
|
It is the third time I post this report because I think that it is very...
|
|
T.EDT
|
Last patient randomized on june,18,2016 + 28 days of following period for...
|
|
T.EDT
|
Thank you Diamond and I am satisfied too but I think that it is not ethical.
|
|
T.EDT
|
In press release concerning the ''Normal Course Issued Bid''...
|
|
T.EDT
|
At this time of the game, with his $400,000 compensation per year, I really...
|
|
T.EDT
|
Spectral told that results should be released before the end of september...
|
|
T.EDT
|
There is no more number indicated in ''Previous Day's Marker...
|
|
T.EDT
|
WEDBUSH REPORT ON JANUARY 28, 2014 ( READ CAREFULLY ) Spectral Diagnostics...
|
|
T.EDT
|
In press release dated june,27,2016, it is written at the second paragraph : ...
|
|
T.EDT
|
It would be nice to have a testimony like this one from a patient treated in...
|
|
T.EDT
|
Try this link for a very good testimony of EUPHRATES trial. -----------------...
|
|
T.EDT
|
For those who never seen this testimony, it is very interesting concerning...
|
|
T.EDT
|
Yesterday, I wrote to Tony Businskas ( Vice-President and CFO of Spectral...
|
|
T.EDT
|
I think that the $60M potential revenue for Expanded Access Program at 42...
|
|
T.EDT
|
WEDBUSH REPORT ON JANUARY 28, 2014 ( READ CAREFULLY ) Spectral Diagnostics...
|
|
T.EDT
|
I will try to value again Spectral shares with a conservative method. First...
|